Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Tenosynovial giant cell tumor, diffuse type as a terminology item and a Genetic and Rare Diseases Information Center resource to the study page.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check71 days agoChange DetectedAdministrative site changes include addition of Revision v3.4.2 and removal of the funding-status notice and Revision v3.4.1, which do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedNotice about a lapse in government funding and NIH status update has been added, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.